Back to Agenda
The Sites Have Spoken: Implementing Paperless Trials and Risk-Based Monitoring from a Site’s Perspective
Session Chair(s)
Penelope K. Manasco, MD, MS
Chief Executive Officer
MANA RBM , United States
This session brings sites that have adopted paperless trials together to provide their opinions and insights into this new approach to clinical trial conduct.
Learning Objective : Identify key factors for the successful adoption of paperless trials for investigative sites; Discuss key technology components and their setup that assist sites in the adoption of technology; Describe key training features that ensure adoption by the sites.
Speaker(s)
Site Satisfaction with a P3 Paperless Clinical Trial
Mary R. Flack, MD
Boehringer-Ingelheim , United States
Clinical Program Leader, Immunology
A Site's Experience with Implementing Electronic Source
Catherine Morimoto
Diablo Clinical Research, United States
Director of Clinical Operations
Implementing eSource for Home Visits by Home Health Nurses
Teresa Suek
Research 3, Inc., United States
President
Have an account?